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Abstract 
Objective: This study hopes to compare the rate of symptom resolution achieved with different recommended speeds of initial 
atropinization as part of treatment of patients presenting with accidental organophosphate insecticide poisoning.  
Methodology: The casual-comparative analysis was conducted at the department of medicine, Liaquat university hospital, upon 
a total of 117 patients from October 2016 to July 2017. Informed consent was acquired from each patient before administering 
each of the recommended dosage regimens.  
Results: The best performing regimen was administration of a beginning bolus of one to two milligrams of atropine, seconded 
shortly (five minutes) by a doubled dose of atropine. This practice of administering a doubled dose after 5 minutes is followed till 
complete atropinization is obtained. Among the many up sides of our most successful regimen, most notable were the facts that, 
administration of a mean dose (25 mg) required not more than twenty minutes, it worked well even for rare cases that required 
rather large quantities of atropine, allowing 75 mg of atropine to be administered in no more than 25–30 minutes, and finally, it 
even catered to the needs of patients that require small doses owing to the fact that the beginning bolus can be a mere 1 mg.  
Conclusion: After careful consideration and deliberation on the obtained results, the use of a dosage regimen with the high pace 
of initial atropinization to halt the adverse effects seems to be the best choice. It shall help to considerably decrease the mortality 
owing to organophosphate poisoning. It addition to that, the use of a simple and easy to follow dosage regimen is more likely to 
be followed correctly. 
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INTRODUCTION: 
Organophosphate (OP) poisoning continues to be a 
matter of great concern, particularly in the 
developing faction of the world. [1-3]. This is 
attributed to the easy access to insecticide/pesticides 
of organophosphate origin owing to the fact that 
many of the developing countries thrive off an 
agricultural economy and products such as 
insecticides and pesticides are readily available. The 
death toll, brought about by toxicity of such 
pesticides may climb up to 0.2 million deaths 
annually. [4-6]  
The untimely demises occur due to failure of 
respiration, weakness of neuromuscular junction, 
central respiratory depression, bronchospasm and 
bronchorrhoea and due to cardiovascular collapse [7]. 
Atropine administration is urgently required in 
sufficient doses to counter the cholinergic signs. [8–
10] This prime step of treatment is often called 
“atropinization”. Following atropinization, airway 
and ventilator support too may be required in severe 
cases. [11] 
Despite the fact that atropine is acknowledged by all 
as a cornerstone of initial treatment, [12] firm 
consensus regarding the atropine dosage regimen and 
the pace of initial administration is yet to be 
achieved. This is mainly due to scarcity of evidence 
pertaining to the matter, particularly, the lack of 
comparative analysis that may put all 
advised/recommended regimens to the test in control 
environments to assess the performance of each 
regimen against the other tests. 
However, even though the precise dosage of atropine 
or its initial pace of administration is not agreed 
upon, there is consensus on the signs that manifest, 
once an adequate dosage of atropine has been 
administered. The signs and symptoms are namely, 
tachycardia, halted sweating and miosis reversal. [13-
14] The clear signs thus ensure that the therapy is 
timely halted and overdose is not administered.  
The aim of this study was thus, to compare all worthy 
atropine dosage regimens and their respected speed 
of initial administration to see how each of the 
regimens and their initial speed of atropinization, in 
particular, fairs when put to the test.  
 
METHODOLOGY: 
The casual-comparative analysis was conducted at 
the department of medicine, Liaquat university 
hospital, upon a total of 117 patients from October 
2017 to July 2017. Patients with a history contact 
with organophosphorus insecticides/pesticides that 
exhibited cholinergic signs and required atropine 
administration were considered eligible for inclusion 
in the study.  
Methods of identification of organophosphorus 
exposure included, history from patient or attendant; 
clinical features shown by patients were assessed for 
consistency with a diagnosis of OP poisoning. Each 
of the 29 separate dosage regimens, their quantity and 
the pace of atropine given to each patient was noted. 
Standard protocols were employed while managing 
the patient. Each dosage regimen was administered to 
three patients and their mean rate of symptom 
resolution was used to enhance accuracy and 
reliability and account for external biases. 
 
 
The symptoms, whose rate of resolution was investigated were the following: 
Depending on the time elapsed since exposure of the patient to organophosphorus. 
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RESULTS: 
The best performing regimen was administration of a 
beginning bolus of one to two milligrams of atropine, 
seconded shortly (five minutes) by a doubled dose of 
atropine. This practice of administering a doubled 
dose after 5 minutes is followed till complete 
atropinization is obtained.  
Among the many up sides of our most successful 
regimen, most notable were the facts that, 
administration of a mean dose (25 mg) required not 
more than twenty minutes, it worked well even for 
rare cases that required rather large quantities of 
atropine, allowing 75 mg of atropine to be 
administered in no more than 25–30 minutes, and 
finally, it even catered to the needs of patients that 
require small doses owing to the fact that the 
beginning bolus can be a mere 1 mg. 
 
 
 
 
 
 
The complete list of recommended dosage regimens & their individual pace are tabulated below. 
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A pictorial depiction of the individual initial speed of atropinization is also provided below: 
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A break-up rate of the resolution rate of muscarinic symptoms is provided below 
 
Fig 3: Gastric cramps went took the most time and were the last to be relieved. 
 
DISCUSSION: 
Severe organophosphate poisoning is a major clinical 
issue in our part of the world with death toll, rising 
up to 0.2 million deaths annually. [4-6] However, 
most deaths occur due to delayed and/or improper 
treatment a regimen which often leads to due to 
failure of respiration, weakness of neuromuscular 
junction, central respiratory depression, 
bronchospasm and bronchorrhoea and due to 
cardiovascular collapse. [7] Research conducted upon 
animals has revealed the primary cause of death to be 
central cholinergic stimulation. [14, 15]  
Atropine is a competitive Ach antagonist at the post-
synaptic muscarinic nerve membrane. It is ideal to 
administer it in an initial dose test dose of 1 to 2 mg 
intravenously (0.05 mg/kg). If no intravenous access 
is available, it can be given intramuscularly.  
Atropine begins to resolve the symptoms of the 
poison and manifests signs of atropinization (if the 
poison is ingested in small amounts) in 1 to 4 minutes 
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after administration and peak effect is observed by 8 
minutes; so, if there is no effect from the 
administered dose, than the administered dose can be 
doubled every 5 minutes until muscarinic findings 
subside. [16] Once the adequate atropine dose has 
been established, this dose should be adjusted to 
maintain a dry tracheobronchial tree for 24 hours. 
The amount of atropine needed may be very large. In 
some cases, hundreds of milligrams of atropine may 
be quired. An atropine drip can be made by 
reconstituting into an infusion of dextrose 5 percent 
water (D5W) or normal saline. There is no specific 
concentration for the drip. Once atropinization has 
been achieved, atropine can be slowly withdrawn. 
[17] 
Glycopyrolate (0.05 mg/kg I.V) may also be used to 
treat the peripheral muscarinic effects. It does not 
penetrate the CNS and will only treat peripheral 
findings. Scopolamine is useful where glycopyrolate 
falls short but it too has its short-comings. Other 
essential drugs that are part of mandatory treatment 
protocol and essential for resolution of nicotinic and 
central receptor symptoms, such as pralidoxime, are 
not discussed here, since it is outside the scope of this 
research.  
 
CONCLUSION: 
After careful consideration and deliberation on the 
obtained results, the use of a dosage regimen with the 
high pace of initial atropinization to halt the adverse 
effects seems to be the best choice. It shall help to 
considerably decrease the mortality owing to 
organophosphate poisoning. It addition to that, the 
use of a simple and easy to follow dosage regimen is 
more likely to be followed correctly. 
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